Tumor-targeted costimulation with antibody-fusion proteins improves bispecific antibody-mediated immune response in presence of immunosuppressive factors

DOI: 10.1080/2162402X.2017.1361594

Keywords: Antibody-fusion proteins, costimulation, cancer immunotherapy, immunosuppression, TNFSF ligands

Full-Text   Cite this paper   Add to My Lib

Abstract:

Full-Text